PTPI - Balance Sheet - Petros Pharmaceuticals, Inc.

Current Liabilities	18 M
Accounts Payable	2.33 M
Short-Term Debt	7.31 M
Other Current Liabilities	8.39 M
Non-Current Liabilities	75.2 M
Long-Term Debt	75.2 K
Other Non-Current Liabilities	75.1 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018
ASSETS
Cash & Cash Equivalents	3.7	13.3	9.4	23.8	17.1	2.1	2.8
Short Term Investments	0	0	0	0	0	0	0
Receivables	0.4	2.2	2.1	2.5	5.2	2.6	3.5
Inventory	1.3	1.6	1.8	0.5	0.8	2.2	6.5
Other Current Assets	3.5	3.2	1.3	3.1	2.9	5.1	3.0
Total Current Assets	7.3	20.4	14.7	30.5	25.9	12.1	15.8
PP&E	0.1	0.3	0.4	0.5	0.6	69.8 K	0
Intangible Assets	0	9.0	12.2	25.3	32.2	38.8	44.1
Goodwill	0	0	0	0	0	0	2.4
Long Term Investments	0	0	0	0	0	0	0
Other Long Term Assets	0	4.2	5.1	11.0	11.1	7.4	4.5
Other Assets	0	0	0	0	0	0	0
Total Assets	10.6	33.8	32.4	67.4	69.9	58.4	66.9
LIABILITIES
Accounts Payable	2.3	1.7	1.8	4.6	5.6	3.8	1.8
Short Term Debt	7.3	1.3	1.2	0	7.2	6.8	19.3
Other Current Liabilities	8.4	5.7	4.0	26.4	29.1	30.5	17.5
Total Current Liabilities	18.0	10.8	7.1	31.0	41.9	41.1	38.5
Long Term Debt	75.2 K	7.0	8.7	0.4	0	7.7	27.9
Deferred Tax Income	0	0	0	0	0	1.4	2.1
Other Liabilities	75.1	3.6	0	0.5	10.5	0.1	57.4 K
Total Liabilities	18.1	21.3	15.7	31.8	52.4	50.3	68.6
EQUITY
Common Stock	1.05 K	298	208	2.07 K	971	29.1	0
Retained Earnings	(113 208.4)	(98.9)	(90.7)	(70.7)	(61.7)	(41.1)	(1.7)
Other Accumulative Comprehensive Income/Loss	0	0	0	0	0	(29.1)	0
Total Equity	(7 467.6)	12.5	16.7	35.5	17.5	8.0	(1.7)
Total Liabilities and Equity	10.6	33.8	32.4	67.4	69.9	58.4	66.9
SHARES OUTSTANDING
Common Shares Outstanding	8.0	1.3	2.1	1.1	0.5	0.2	100 K

Free